Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form

Cannabis and Cannabinoid Research

Volumn 1, Issue 1, 2016, Pages 252-261

  Bonn Miller, Marcel O ^a,b,c   Heinz, Adrienne J ^a   Smith, Everett V ^d   Bruno, Raimondo ^e   Adamson, Simon ^f  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e UNIVERSITY OF TASMANIA   (Australia)

^f UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

assessment; cannabis; cannabis use disorder; screening

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CANNABIS ADDICTION; CANNABIS USE DISORDER IDENTIFICATION TEST SHORT FORM; CLINICAL EFFECTIVENESS; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DSM-5; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 85041058787     PISSN: None     EISSN: 23788763     Source Type: Journal    
DOI: 10.1089/can.2016.0022     Document Type: Article

References (39)

1. United Nations Office on Drugs and Crime. World drug report 2014 (United Nations publication, Sales No. E.14.XI.7). Vienna, Austria: United Nations Office on Drugs and Crime, 2014.
2. Substance Abuse and Mental Health Services Administration. Results from the 2013 national survey on drug use and health: summary of national findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
3. Australian Institute of Health and Welfare. National drug strategy household survey detailed report 2013. Drug statistics series no. 28 Cat. no. PHE 183. Canberra, Australia: Australian Institute of Health and Welfare, 2014.
4. Bonn-Miller MO, Harris AH, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv. 2012;9:404-416.
5. Volkow ND, Baler RD, Compton WM, et al. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219-2227.
6. Roffman RA, Stephens RS. Cannabis dependence: its nature, consequences, and treatment. Cambridge, UK; New York: Cambridge University Press, 2006.
7. Norberg MM, Gates P, Dillon P, et al. Screening and managing cannabis use: comparing GP's and nurses' knowledge, beliefs, and behavior. Subst Abuse Treat Prev Policy. 2012;7:31.
8. Bonn-Miller MO, Bucossi MM, Trafton JA. The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA. Mil Med. 2012;177:786-788.
9. Babor TF, McRee BG, Kassebaum PA, et al. Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abuse. 2007;28:7-30.
10. Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88:791-804.
11. Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158: 1789-1795.
12. Bradley KA, Lapham GT, Hawkins EJ, et al. Quality concerns with routine alcohol screening in VA clinical settings. J Gen Intern Med. 2011;26:299-306.
13. Bradley KA, Williams EC, Achtmeyer CE, et al. Implementation of evidence-based alcohol screening in the Veterans Health Administration. Am J Manag Care. 2006;12:597-606.
14. Bujarski SJ, Galang JN, Short NA, et al. Cannabis use disorder treatment barriers and facilitators among veterans with PTSD. Psychol Addict Behav. 2016;30:73-81.
15. Adamson SJ, Sellman JD. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev. 2003;22:309-315.
16. Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110:137-143.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association, 2000.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association, 2013.
19. Budney AJ, Hughes JR, Moore BA, et al. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161:1967-1977.
20. Ramo DE, Liu H, Prochaska JJ. Reliability and validity of young adults' anonymous online reports of marijuana use and thoughts about use. Psychol Addict Behav. 2012;26:801-811.
21. Annaheim B, Scotto TJ, Gmel G. Revising the Cannabis Use Disorders Identification Test (CUDIT) by means of item response theory. Int J Methods Psychiatr Res. 2010;19:142-155.
22. Embretson SE, Hershberger SL. The new rules of measurement: what every psychologist and educator should know. Mahwah, NJ: Erlbaum, 1999.
23. Lei P-W, Wu Q, DiPerna JC, et al. Developing short forms of the EARLI Numeracy measures: comparison of item selection methods. Educ Psychol Meas. 2009;69:825-842.
24. Weisenburgh-Snyder A, Chen L, Dodd B. Applying the Rasch model to develop a screening measure for at-risk and advance beginning readers to enhance response-to-intervention frameworks. Annual meeting of the American Educational Research Association, New Orleans, LA, 2011.
25. Graves RE, Bezeau SC, Fogarty J, et al. Boston naming test short forms: a comparison of previous forms with new item response theory based forms. J Clin Exp Neuropsychol. 2004;26:891-902.
26. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. New York: Biometrics Research, New York State Psychiatric Institute, 2002.
27. Grant BF, Harford TC, Dawson DA, et al. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39:37-44.
28. Compton WM, Cottler LB, Dorsey KB, et al. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. Drug Alcohol Depend. 1996;41:179-187.
29. Rasch G. Probabilistic models for some intelligence and attainment tests. Expanded ed. Chicago, IL: University of Chicago Press, 1980.
30. Linacre JM. Winsteps- Rasch measurement computer program user's guide. Winsteps.com: Beaverton, Oregon, 2006.
31. Linacre JM. Winsteps- Rasch measurement computer program. Winsteps.com: Beaverton, Oregon, 2010.
32. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
33. MedCalc Statistical Software version 14.8.1. MedCalc Software bvba, Ostend, Belgium, 2014. Available at: www.medcalc.org
34. Wright BD. Multiple regression with WINSTEPS: a Rasch solution to regression confusion. Multiple Linear Regression Viewpoints. 2000;26:42-45.
35. Lansing AE, Ivnik RJ, Cullum CM, et al. An empirically derived short form of the Boston naming test. Arch Clin Neuropsychol. 1999;14:481-487.
36. Mewton L, Slade T, Teesson M. An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data. J Stud Alcohol Drugs. 2013;74:614-621.
37. Compton WM, Grant BF, Colliver JD, et al. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291:2114-2121.
38. Compton WM, Saha TD, Conway KP, et al. The role of cannabis use within a dimensional approach to cannabis use disorders. Drug Alcohol Depend. 2009;100:221-227.
39. Adamson SJ, Kay-Lambkin FJ, Baker A, et al. Measuring change in cannabis use. Addict Res Theory. 2015;23:43-49.